An interdisciplinary team from The University of Texas Medical Branch at Galveston and Profectus BioSciences, Inc. has developed a quick-acting vaccine that is both safe and effective with a single dose against the Ebola strain that killed thousands of people in West Africa last year.
These findings are detailed in the new edition of Nature.
During 2014, the outbreak of the West African Makona strain of Ebola Zaire virus killed nearly 10,000 and caused worldwide concern. With increasing population growth in West Africa, the frequency of contact between humans and natural Ebola virus hosts such as bats will likely rise, potentially leading to more catastrophic outbreaks.
Many vaccine approaches have shown promise in being able to protect nonhuman primates against Ebola Zaire. In response to the Ebola Zaire outbreak, several of these vaccines have been fast tracked for human use.
One of those vaccines, developed by UTMB and Profectus, has been undergoing testing in the Galveston National Laboratory, the only fully operational Biosafety Level 4 laboratory on an academic campus in the U.S.
“These findings may pave the way for the identification and manufacture of safer, single dose, high efficiency vaccines to combat current and future Ebola outbreaks,” said Thomas Geisbert, UTMB professor of microbiology and immunology. “We are excited at the possibility of helping develop a way to stop this deadly disease. We have a lot of more work to accomplish but it’s important to note that this is a big step.”
The research team developed a vaccine effective against Ebola Zaire with a single dose in a nonhuman primate model. This new vaccine employs a virus not harmful to humans called vesicular stomatitis virus that had a part of the Ebola virus inserted into it. This “Trojan horse” vaccine safely triggered an immune response against Ebola Zaire.
To address any possible safety concerns associated with this vaccine, the team developed two next generation candidate vaccines that contain further weakened forms of the vaccine. Both of these vaccines produced an approximately ten-fold lower level of virus in the blood compared to the first generation vaccine.
“It was not known whether any of these vaccines could provide protection against the new outbreak West African Makona strain of Ebola Zaire currently circulating in Guinea,” said John Eldridge, Chief Scientific Officer-Vaccines at Profectus Biosciences, Inc. “Our findings show that our candidate vaccines provided complete, single dose protection from a lethal amount of the Makona strain of Ebola virus.”
The Latest on: Ebola
via Google News
The Latest on: Ebola
- Medics fight to contain Ebola virus outbreak in Zaire - archive, 1995on May 12, 2020 at 9:30 pm
Experts warn epidemics are on the increase as people migrate and interfere with the environment, transferring new diseases from animal hosts to humans ...
- Doctor who survived Ebola: US needs more coronavirus testing to prevent 'constant interruptions'on May 12, 2020 at 7:56 pm
"We don't have what we need in place to be able to do what needs to be done well, the good bread-and-butter public health: testing, contact tracing, isolating," said Dr. Craig Spencer of New ...
- Telehealth tools developed for Ebola improve COVID-19 careon May 11, 2020 at 10:06 am
Telemedicine tools developed at UVA Health to battle Ebola have huge potential in the fight against COVID-19, UVA experts report in a new scientific paper. The tools, they say, allow doctors to ...
- How Ebola Helped Africa Prepare for Coronaviruson May 8, 2020 at 8:00 pm
HIV/Aids, Lassa fever, and tuberculosis are just some of the communicable diseases that African health experts are used to dealing with, and many realized the danger of the coronavirus as soon as they ...
- ‘Finally, a virus got me.’ Scientist who fought Ebola and HIV reflects on facing death from COVID-19on May 8, 2020 at 2:30 pm
Virologist Peter Piot, director of the London School of Hygiene & Tropical Medicine, fell ill with COVID-19 in mid-March. He spent a week in a hospital and has been recovering at his home in London ...
- How Lessons From Ebola Can Help Fight COVID-19on May 8, 2020 at 3:12 am
An infectious disease specialist in Atlanta is drawing on his experiences treating Ebola patients while caring for those with COVID-19.
- The double burden of coronavirus and Ebola in eastern DRCon May 8, 2020 at 2:24 am
COVID-19 comes to complicate an already difficult situation, as the region struggles from both armed conflict and an Ebola outbreak that has lasted nearly two years and infected thousands.
- Ebola Vaccine Market Research – Industry Analysis, Growth, Size, Share, Trends, Forecast to 2026on May 6, 2020 at 1:21 pm
May 06, 2020 (AB Digital via COMTEX) -- Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the ...
- Ebola experts’ tips to fight COVID-19: Listen. Build trust. Show respect.on May 5, 2020 at 8:15 am
As COVID-19’s spread continues, countries are learning lessons from past epidemics, particularly the 2014-2016 Ebola outbreak in West Africa.
- Viral genomics in Ebola virus researchon May 4, 2020 at 9:15 am
Filoviruses such as Ebola virus pose a substantial health risk to humans. Advances in genomic technologies have enabled the rapid, large-scale generation of virus sequence data at the location of ...
via Bing News